A protein kinase that activates cyclin-dependent kinases has been identified as a related catalytic subunit in association with a novel cyclin regulatory subunit -it is itself a cyclin-dependent kinase.
Progression through the eukaryotic cell cycle is controlled by the sequential formation, activation and inactivation of a series of protein serine/threonine kinases, the cyclin-dependent kinases (CDKs). Each CDK is thought to phosphorylate specific substrates and to coordinate the changes that occur during a particular transition in the cell cycle. Because of their central role, a great deal of effort has been devoted to understanding the regulation of CDKs and several mechanisms have been identified. Availability of their essential cyclin subunits is restricted to the appropriate period in the cycle by control of cyclin synthesis and degradation. In addition, several CDK-cyclin complexes are inhibited by the binding of small protein inhibitors, the abundance of which is also tightly controlled. Furthermore, the activities of CDKs are regulated post-translationally by reversible phosphorylation of their catalytic subunits (Fig. 1) .
Regulation by phosphorylation is best understood for the archetypal CDK-cyclin complex formed between a B-type cyclin and CDK1, usually called Cdc2 after the gene that encodes its homologue in the fission yeast, Schizosaccharomyces pombe. The Cdc2-cyclin B kinase complex forms MPF (first purified as a 'maturation-promoting factor' from Xenopus oocytes) and induces the events of metaphase in all eukaryotes that have been studied. Phosphorylation of Cdc2 at sites near to its active site -tyrosine 15 and, in vertebrates, threonine 14 -inhibits the activity of the kinase complex. The enzymes that regulate the phosphorylation state of these Fig. 1 . Activation of Cdc2-cyclin B protein kinase (MPF). As cyclin B is synthesized during S and G2 phases of the cell cycle, it associates with Cdc2. Active CDK-activating kinase (CAK) phosphorylates Cdc2 at threonine 161, stabilizing its association with cyclin B, but the complex is not immediately active because the Cdc2 subunit is phosphorylated by other kinases at inhibitory sites, threonine 14 and tyrosine 15 . Final activation of MPF occurs when these sites are dephosphorylated by CDC25 phosphatase. This step is inhibited by a type-2A protein phosphatase but stimulated by MPF as part of a positive feedback mechanism. Active MPF induces the cell to enter metaphase. MPF is switched off when cyclin B is degraded and threonine 161 dephosphorylated. Other CDKs may be activated more rapidly, without being subject to phosphorylation at inhibitory sites. CAK consists of a catalytic subunit related to Cdc2 (MO1 5/CDK7) along with a cyclin, cyclin H; an activating phosphorylation at threonine 176 of the MO1 5/CDK7 subunit is required for activity. The role of phosphorylation at an additional site, serine 170, is unknown. Distinct, unidentified kinases may be responsible for phosphorylating residues of M01 5/CDK7. The protein phosphatases that act on these sites and on threonine 161 of Cdc2 are unknown.
sites are themselves acutely controlled and responsive to intracellular signals that delay entry into mitosis if, for example, DNA replication has not been successfully completed. Conversely, phosphorylation at an additional site, threonine 161, which is in a region known as the T loop of the kinase's structure, is essential for the activity of the Cdc2-cyclin B complex [1] . This site is conserved in other CDKs, and they all seem to be phosphorylated in a similar manner. Indeed, many other protein kinases have activating phosphorylation sites in the corresponding region [2] (Fig. 2 ).
Phosphorylation at threonine 161 is induced when a newly synthesized cyclin B molecule associates with Cdc2, possibly because cyclin binding induces a conformational change in the catalytic subunit. The phosphorylation is catalyzed by a distinct kinase activity, called CAK, for CDK-activating kinase [3] . Recently, this kinase has been purified by several research teams, and its catalytic subunit shown to be the product of the M015 gene [4] [5] [6] , which was originally isolated from a Xenopus cDNA library in a search for genes encoding kinase catalytic subunits related to Cdc2 [7] . This discovery immediately suggested a number of intriguing possibilities about the mechanism of activation of CAK itself-as its catalytic subunit is related to Cdc2, could its activity be controlled in similar ways?
As purified, CAK contains other polypeptides besides MO15. One of these has been identified by Fisher and Morgan [8] as a novel member of the cyclin family, cyclin H. Independently, Makela et al. [9] isolated cyclin H using the 'two-hybrid' screen, which relies on coexpression of genes in yeast, to look for proteins that interact with MO15. Formation of an active kinase requires the association of cyclin H with MO15, and can be reconstituted in vitro using recombinant proteins, demonstrating that CAK is itself a cyclin-dependent kinase [8, 9] . This makes MO15 the seventh member of the family to be confirmed as being dependent on a cyclin for activity, so it is now dubbed CDK7 (CDKs are being sequentially numbered as they are identified, whereas cyclins receive a letter). Furthermore, for CAK to be active requires phosphorylation of M015/CDK7 in the T loop region at threonine 176 (Fig. 2) ; there is also phosphorylation at serine 170, although it is not clear what role this phosphorylation might have, as it is dispensable for kinase activity [8,10,11]. Threonine 176 phosphorylation in MO15/CDK7 complexes may be catalyzed by yet another kinase that acts 'upstream' of CAK, although it is also possible that it results from an autophosphorylation reaction [8] .
So does the activity of CAK change during the cell cycle? Like other CDKs, the M015/CDK7 catalytic subunit is present throughout the cycle. Although we do not yet know whether the amount of cyclin H changes, the kinase seems to be constitutively active during the cell cycle [11 -14] . The amount of MO15/CDK7 decreases in cells when they leave the cell cycle and Fig. 2 . Amino-acid sequences of the T-loop region of CDKs and the corresponding regions of some other protein kinases for which phosphorylation sites have been determined [2] . The kinases are: Cdc2; CDK2; CDK4; M015/CDK7; a mitogenactivated protein kinase (MAPK), p40mapk; a MAP kinase kinase (MKK); and cAMP-dependent protein kinase (PKA). Phosphorylated residues are highlighted in blue.
become quiescent, but this seems to be the case for a number of other CDKs and cyclins, including substrates of CAK [11, 12] . But there are a number of possible reasons why changes in activity might have been overlooked. The association of regulatory molecules, or changes in phosphorylation, could be lost when the complex is diluted in buffers prior to assay in vitro. Alternatively, CAK may be constitutively active, but its ability to phosphorylate CDKs controlled through other proteins binding to the substrate, or by modulation of a protein phosphatase (as yet unidentified) that opposes the actions of CAK. Phosphorylation of threonine 161 in Cdc2 is not readily reversed once a stable complex between Cdc2 and cyclin B has formed, but there could be an initial, transient phase, during which an okadaic-acid-sensitive phosphatase may compete with CAK ( Fig. 1) [15] .
It is also possible that a similar phosphatase negatively regulates formation of active CAK itself, and this phosphatase might be down-regulated upon entry into mitosis. One observation of potential interest here is that the rate of activation of recombinant MO 15/CDK7 added to cell-free extracts of Xenopus eggs is greater in a mitotic extract than in an interphase one [11] . Nevertheless, in such extracts, Cdc2 seems to get phosphorylated rapidly when cyclin B binds [3] , and the major control over the timing of activation of the Cdc2-cyclin B protein kinase is through the inhibitory phosphorylation sites, threonine 14 and tyrosine 15.
In somatic cells, there might be levels of control that do not occur in Xenopus egg extracts: for instance, the subcellular distribution of the enzyme could be altered. In such cells, M015/CDK7 is predominantly nuclear, as it is in Xenopus oocytes, which contain a large nucleus, the germinal vesicle [7, 10, [12] [13] [14] . MO15/CDK7 has a classical nuclear localization sequence within its primary structure that is required for direction to the nucleus and formation with cyclin H of an active CAK complex [10, 14] . Some of the CDKs that are potential substrates of CAK are also found in the nucleus, although it is not clear how a nuclear CAK could act upon Cdc2-cyclin B complexes, which are thought to be phosphorylated in the cytoplasm. This dilemma highlights the sparse and sometimes conflicting information that we have concerning nuclear-cytoplasmic communication during CDK activation -perhaps the process is highly dynamic, with kinases and phosphatases shuttling in and out of the nucleus [12] .
Even if there are no dramatic changes in the ability of CAK to influence the timing of CDK activation, could phosphorylation at threonine 161 in Cdc2 (and the corresponding sites in other CDKs) play a more subtle role in the process? Phosphorylation stabilizes the association of the CDK catalytic subunit with cyclin, and the site becomes resistant to dephosphorylation once the complex has formed [10, 15, 16] . This may ensure that the kinase complex remains stable and active until after it has completed its function, when progression to the next phase of the cell cycle is warranted. Cyclin degradation is then triggered. In the absence of cyclin, threonine 161 is no longer a substrate for CAK [3] and the site becomes exposed again to phosphatase action, returning Cdc2 to its inactive, interphase state [17] (Fig.  1) . In other words, the process of CDK activation has directionality. Other controls may impinge upon the activity of a CDK to arrest cell-cycle progression, but. there is no going back to the state of the previous cellcycle phase.
Of course, a number of additional points are raised by the latest results. There are some hints that putative regulatory subunits other than cyclin H may be found in purified complexes [8,10,12] -these may give specificity of activity towards different substrates, or may be subject to different controls. And although MO15/CDK7 complexed to cyclin H has been shown to be capable of phosphorylating CDK2 [5], CDK4 [18] and an unclassified CDK from Caenorhabditis [4] , there may be additional homologues of MO15 with preference for particular substrates. No dramatic changes in CAK activity across the normal cell cycle have been found, but phosphorylation in the T loop of CDKs could be responsive to signals that alter the progression of the cell cycle under adverse conditions.
